Date published: 2026-5-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

VER-3323 hemifumarate salt

0.0(0)
Write a reviewAsk a question

Alternate Names:
(S)-1-(6-Bromo-2,3-dihydroindol-1-yl)-2-propylamine hemifumarate salt
Application:
VER-3323 hemifumarate salt is a SR-2C/SR-2B agonist
Molecular Weight:
313.19
Molecular Formula:
C11H15N2Br•1/2C4H4O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

VER-3323 hemifumarate salt may act to be a SR-2C/SR-2B (5-HT2C/ 5-HT2B serotonin receptor) agonist. Its mechanism of action is centered around the selective and potent inhibition of enzymes, leading to modulation of the signaling pathways that are for cellular function and homeostasis. In research applications, VER-3323 hemifumarate salt serves as useful for investigating the complex mechanisms underlying cell signaling and regulation. By precisely targeting these pathways, it allows scientists to dissect the roles of specific enzymes and signaling molecules in various cellular processes, such as proliferation, differentiation, and apoptosis. This specificity not only aids in the elucidation of intricate biological mechanisms but also in the identification of potential targets for novel research avenues. As a hemifumarate salt, the compound exhibits improved solubility and stability, making it more amenable for use in a variety of experimental conditions.


VER-3323 hemifumarate salt References

  1. The melanocortin system and its role in obesity and cachexia.  |  Goodfellow, VS. and Saunders, J. 2003. Curr Top Med Chem. 3: 855-83. PMID: 12678837
  2. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.  |  Knight, AR., et al. 2004. Naunyn Schmiedebergs Arch Pharmacol. 370: 114-23. PMID: 15322733
  3. Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity.  |  Halford, JC., et al. 2005. Curr Drug Targets. 6: 201-13. PMID: 15777190
  4. Involvement of 5-HT receptors in the regulation of food intake in Siberian hamsters.  |  Schuhler, S., et al. 2005. J Neuroendocrinol. 17: 276-85. PMID: 15869562
  5. Serotonin 5-ht2c receptor agonists: potential for the treatment of obesity.  |  Miller, KJ. 2005. Mol Interv. 5: 282-91. PMID: 16249524
  6. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.  |  Song, J., et al. 2005. Assay Drug Dev Technol. 3: 649-59. PMID: 16438660
  7. 5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents.  |  Nilsson, BM. 2006. J Med Chem. 49: 4023-34. PMID: 16821762
  8. Serotonin and norepinephrine reuptake inhibition and eating behavior.  |  Hainer, V., et al. 2006. Ann N Y Acad Sci. 1083: 252-69. PMID: 17148744
  9. An old dog learns a new trick: regulation of peripheral glucose homeostasis by the serotonin (5-HT)2C receptor.  |  Miller, KJ. and Azzara, AV. 2008. Mol Interv. 8: 73-7. PMID: 18403651
  10. Acceptability of urine-based screening for Chlamydia trachomatis in asymptomatic young men: a systematic review.  |  Marrazzo, JM. and Scholes, D. 2008. Sex Transm Dis. 35: S28-33. PMID: 18418291
  11. Pharmacological targeting of the serotonergic system for the treatment of obesity.  |  Garfield, AS. and Heisler, LK. 2009. J Physiol. 587: 49-60. PMID: 19029184
  12. Pharmacological and genetic interventions in serotonin (5-HT)(2C) receptors to alter drug abuse and dependence processes.  |  Filip, M., et al. 2012. Brain Res. 1476: 132-53. PMID: 22494568
  13. Identification of structural determinants of ligand selectivity in 5-HT₂ receptor subtypes on the basis of protein-ligand interactions.  |  Jang, JW., et al. 2012. J Mol Graph Model. 38: 342-53. PMID: 23085173

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

VER-3323 hemifumarate salt, 50 mg

sc-301968
50 mg
$650.00